1. Functional polymorphisms of innate immunity receptors are not risk factors for the non‐SBP type bacterial infections in cirrhosis. (17th January 2018) Authors: Dinya, Tamas; Tornai, Tamas; Vitalis, Zsuzsanna; Tornai, Istvan; Balogh, Boglárka; Tornai, David; Antal‐Szalmas, Peter; Sumegi, Andrea; Andrikovics, Hajnalka; Bors, Andras; Tordai, Attila; Papp, Maria Journal: Liver international Issue: Volume 38:Number 7(2018) Page Start: 1242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections. (28th February 2017) Authors: Foldi, Ildiko; Tornai, Tamas; Tornai, David; Sipeki, Nora; Vitalis, Zsuzsanna; Tornai, Istvan; Dinya, Tamas; Antal‐Szalmas, Peter; Papp, Maria Journal: Liver international Issue: Volume 37:Number 7(2017) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Macrophage activation marker, soluble CD163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infection. (5th May 2016) Authors: Tornai, Tamas; Vitalis, Zsuzsanna; Sipeki, Nora; Dinya, Tamas; Tornai, David; Antal‐Szalmas, Peter; Karanyi, Zsolt; Tornai, Istvan; Papp, Maria Journal: Liver international Issue: Volume 36:Number 11(2016) Page Start: 1628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗